In Print

Springer Nature: Microbiome diagnostics and interventions in health and disease

2021

Manuscripts in Revision

Drug Repurposing for ExoN of SARS Cov2

24 June 2020

More

Preprints

Ribavirin-SARS Cov2 RNA-dependent RNA polymerase docking: Drug Repurposing

22 March 2020

More

Ivermectin- SARS Cov2 helicase molecular docking: Drug Repurposing

03 May 2020

More

Secondary co-infections in COVID using RNA-sequencing data: Patient genome-data analysis

11 April 2020

More

Protective role of BCG vaccine in COVID: a hypothesis

10 April 2020

More

Protective role of Vitamin D in COVID: a hypothesis

01 May 2020

More

Repurposing Niclosamide for COVID: suggested mechanisms

27 March 2020

More

Intellectual Property - Patent Applied

Unique-regions SARS Cov2 sequencing and any infectious/other disease screening (Provisional Patent Application Number - 202021023223; miBiome)

Low-cost NGS for SARS Cov2 and any infectious/other disease screening (Provisional Patent Application Number - 202041030440; University of Hyderabad & miBiome)